Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Diabetes Risk Clusters In Households
TUESDAY, Aug. 19, 2025 — Diabetes risk appears to cluster in households, a new study says. Three-quarters of people at risk for developing type 2 diabetes are living under the same roof as another p...
Diabetes Risk Commonly Clustered Within Households
TUESDAY, Aug. 19, 2025 – Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of...
Saliva Insulin Can Differentiate Hyperinsulinemia in Normoglycemic People
MONDAY, Aug. 18, 2025 – Saliva insulin can differentiate between normal and hyperinsulinemic responses among normoglycemic adults with different body mass index (BMI) classes, according to a study...
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
THURSDAY, Aug. 14, 2025 – In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by...
Coffee Is Mostly Safe, Study Finds, But Some Contaminants Remain
WEDNESDAY, Aug. 13, 2025 — Your morning coffee is mostly free from harmful levels of toxins and contaminants, but a new investigation shows there’s room for improvement. “While some contaminants were ...
DASH Diet Modified for Diabetes Lowers Blood Glucose Levels
WEDNESDAY, Aug. 13, 2025 – A modified version of the Dietary Approaches to Stop Hypertension (DASH) diet is effective at lowering glucose in adults with type 2 diabetes, according to a study...
GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
TUESDAY, Aug. 12, 2025 – For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic...
1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says
FRIDAY, Aug. 8, 2025 — More than 1 in 10 Americans have used a GLP-1 drug for weight loss, a new survey by the RAND research group reveals. About 12% say they’ve tried GLP-1 drugs, like Ozempic, Weg...
New Weight Loss Pill From Eli Lilly, Orforglipron, Shows Promise in Early Study
FRIDAY, Aug. 8, 2025 — A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, orforglipron helped patients lose an a...
French Fries Linked to Higher Odds for Type 2 Diabetes
THURSDAY, Aug. 7, 2025 — The next time you’re asked "Fries with that?," maybe say no: Regular consumption of the potato-based treat raises your odds of type 2 diabetes by 20%, new research shows. On ...
Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults
THURSDAY, Aug. 7, 2025 – A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have...
Higher Intake of Total Potatoes Linked to Type 2 Diabetes Risk
THURSDAY, Aug. 7, 2025 – A higher intake of total potatoes, especially French fries, is associated with an increased risk for type 2 diabetes (T2D), according to a study published online Aug. 6 in...
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
WEDNESDAY, Aug. 6, 2025 – Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus (T2DM), according to...
GLP-1 Receptor Agonist Use Linked to Nonarteritic Anterior Ischemic Optic Neuropathy
TUESDAY, Aug. 5, 2025 – For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION),...
New Health Record System Aims to Make Sharing Info Easier, Trump Says
FRIDAY, Aug. 1, 2025 — President Donald Trump has introduced a new effort to help Americans more easily share their health records with doctors, using new technology and artificial intelligence (AI) t...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Mounjaro, Victoza, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N